6 Most Studied Research Peptides in 2026

BPC-157, Epithalon, and 4 Other Peptide Compounds Dominating Lab Research in 2026

Dover, United States – May 27, 2026 / CHEAT CODES INC /

cheat codes has published a ranked research review identifying the six most studied peptide compounds in peer-reviewed literature as of 2026, covering in vitro and in vivo findings across BPC-157, TB-500, CJC-1295, Ipamorelin, Selank, and Epithalon. The review arrives as laboratory demand for catalogued, reproducible peptide data continues to shape procurement decisions among research institutions sourcing research peptides for preclinical studies.

Six Peptide Compounds at the Center of 2026 Laboratory Research

Published science has positioned six peptide compounds as the most documented subjects in current preclinical literature. Each entry in the cheat codes review is evaluated strictly on biochemical profile, volume of peer-reviewed citations, and documented in vitro or in vivo outcomes.

1. BPC-157 (Body Protection Compound-157)

BPC-157 is a 15-amino acid sequence derived from a protective gastric protein. BPC-157 research spans over two decades of published animal model studies, with documented findings in tendon-to-bone healing, nitric oxide pathway modulation, and gastrointestinal mucosal integrity. A frequently cited 2019 study in the Journal of Physiology – Paris recorded accelerated Achilles tendon repair in rat models. Current research status: active in multiple in vivo rodent model protocols.

2. TB-500 (Thymosin Beta-4)

Thymosin Beta-4 is a 43-amino acid peptide involved in actin sequestration and cell migration signaling. In vitro studies have identified its role in endothelial cell proliferation and wound closure assays. A 2016 publication in the Annals of the New York Academy of Sciences documented its involvement in cardiac tissue repair pathways following ischemic events in animal models. Research status: ongoing in cardiovascular and connective tissue in vivo models.

3. CJC-1295

CJC-1295 is a synthetic analogue of growth hormone-releasing hormone (GHRH), modified with drug affinity complex (DAC) technology to extend its plasma half-life. Peer-reviewed pharmacokinetic studies, including a 2006 paper published in the Journal of Clinical Endocrinology & Metabolism, documented sustained growth hormone elevation over six days in animal and early-phase human cell studies. Research status: widely referenced in endocrinological peptide compound literature.

4. Ipamorelin

Ipamorelin is a selective growth hormone secretagogue and ghrelin receptor agonist. Unlike broader secretagogues, its in vitro selectivity profile shows minimal cross-reactivity with cortisol or prolactin pathways, a distinction documented in a 1998 study in the European Journal of Endocrinology. In vivo rat model data has further examined its effects on bone density markers. Research status: active in metabolic and endocrine preclinical pipelines.

5. Selank

Selank is a heptapeptide analogue of the immunomodulatory peptide tuftsin. Russian Academy of Sciences publications document its effects on GABA-A receptor modulation and enkephalin stabilization in rodent models. In vitro studies have examined its influence on interleukin-6 expression. Over 30 peer-reviewed studies referencing Selank have been indexed in international databases as of 2024. Research status: most actively studied within neurological and immunological in vivo frameworks.

6. Epithalon (Epitalon)

Epithalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from the pineal peptide preparation epithalamin. Its most cited research direction involves telomerase activation in somatic cells, with a 2003 study in Neuroendocrinology Letters reporting telomere elongation observed in human somatic cell cultures. Additional in vivo findings in aged animal models have examined circadian rhythm and melatonin synthesis pathways. Research status: cited across gerontological and cell biology literature.

Methodology and Literature Framework

The cheat codes review drew exclusively from indexed peer-reviewed publications, in vitro assay data, and documented in vivo animal model outcomes. No findings reference human clinical application, and all compound descriptions are framed within the boundaries of laboratory research contexts. The review excludes anecdotal, commercial, or non-peer-reviewed sources.

“This review covers six peptide compounds with a combined peer-reviewed citation record spanning more than 25 years of published science,” said Dr. Marcus Hale, Director of Research Curation at cheat codes. “The intent is to give laboratory researchers a consolidated reference point grounded entirely in documented in vitro and in vivo data.”

Research Compound Availability Through cheat codes Peptides

All six peptide compounds discussed in the review are available for laboratory procurement through Cheat Codes Peptides, which supplies catalogued peptide compounds strictly for in vitro and in vivo research use. Each compound is provided with documentation aligned to laboratory research standards. The full review and compound specifications are accessible through the cheat codes research library.

About cheat codes

cheat codes is a laboratory research compound supplier providing peptide compounds to preclinical research environments. Its catalogue includes documented peptide sequences referenced in peer-reviewed literature, supplied exclusively for in vitro and in vivo research applications.

Learn more at CHEAT CODES INC